Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sherr

Showing results (51-60 of 290) with videos related to

Pageof 29
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2006
Activation of multiple mitogen-activated protein kinases in pro/pre-B cells by GW7845, a peroxisome proliferator-activated receptor gamma agonist, and their contribution to GW7845-induced apoptosisJennifer J Schlezinger, Jessica K Emberley, David H Sherr
Biochemical Pharmacology|October 14, 2008
Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressorMark E Hahn, Lenka L Allan, David H Sherr
American Journal of Medical Genetics. Part A|August 9, 2006
Mutation analysis of the FRAS1 gene demonstrates new mutations in a propositus with Fraser syndromeA Slavotinek, C Li, E H Sherr, et al.
The Journal of Experimental Medicine|February 1, 1983
Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responsesD H Sherr, M Minami, K Okuda, et al.
Pediatric Neurology|April 18, 2022
De Novo GLI3 Pathogenic Variants May Cause Hypotonia and a Range of Brain Malformations Without Skeletal AbnormalitiesLyna Siafa, Emanuela Argilli, Elliott H Sherr, et al.
BMC Medical Genomics|August 1, 2016
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancerHsiao-Rong Chen, David H Sherr, Zhenjun Hu, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1990
A function for Ly-1+ B cellsJ A Hardin, K Vos, Y Kawano, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1992
Interleukin 4 induces the maturation of idiotype-specific regulatory B cell populationsJ A Hardin, M Gibson, E Grant, et al.
The Journal of Experimental Medicine|August 1, 1981
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XI. Pseudogenetic restrictions of hybridoma suppressor factorsK Okuda, M Minami, D H Sherr, et al.
American Journal of Medical Genetics. Part A|May 20, 2014
De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG syndrome and Kabuki syndromeSanjin Tunovic, James Barkovich, Elliott H Sherr, et al.
Pageof 29

Showing results (51-60 of 290) with videos related to

Sort By:
Pageof 29
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2006
Activation of multiple mitogen-activated protein kinases in pro/pre-B cells by GW7845, a peroxisome proliferator-activated receptor gamma agonist, and their contribution to GW7845-induced apoptosisJennifer J Schlezinger, Jessica K Emberley, David H Sherr
Biochemical Pharmacology|October 14, 2008
Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressorMark E Hahn, Lenka L Allan, David H Sherr
American Journal of Medical Genetics. Part A|August 9, 2006
Mutation analysis of the FRAS1 gene demonstrates new mutations in a propositus with Fraser syndromeA Slavotinek, C Li, E H Sherr, et al.
The Journal of Experimental Medicine|February 1, 1983
Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responsesD H Sherr, M Minami, K Okuda, et al.
Pediatric Neurology|April 18, 2022
De Novo GLI3 Pathogenic Variants May Cause Hypotonia and a Range of Brain Malformations Without Skeletal AbnormalitiesLyna Siafa, Emanuela Argilli, Elliott H Sherr, et al.
BMC Medical Genomics|August 1, 2016
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancerHsiao-Rong Chen, David H Sherr, Zhenjun Hu, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1990
A function for Ly-1+ B cellsJ A Hardin, K Vos, Y Kawano, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1992
Interleukin 4 induces the maturation of idiotype-specific regulatory B cell populationsJ A Hardin, M Gibson, E Grant, et al.
The Journal of Experimental Medicine|August 1, 1981
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XI. Pseudogenetic restrictions of hybridoma suppressor factorsK Okuda, M Minami, D H Sherr, et al.
American Journal of Medical Genetics. Part A|May 20, 2014
De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG syndrome and Kabuki syndromeSanjin Tunovic, James Barkovich, Elliott H Sherr, et al.
Pageof 29